US Hospital Hemostasis Testing Market: Forecasts for 40 Coagulation Assays, Supplier Shares, 2019-2023

This new report contains 411 pages, 28 tables, and presents a comprehensive analysis of the US hospital coagulation testing market, including: 

  • Major issues pertaining to the US hospital coagulation laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. 
  • Volume and sales forecasts for 40 coagulation procedures performed in US hospitals, including typical coagulation daily work loads. 
  • Review of current instrumentation technologies, and a feature comparison of leading analyzers. 
  • Reagent and instrument sales forecasts. 
  • Sales and market shares of leading reagent and instrument suppliers. 
  • Review of coagulation technologies and their potential market applications. 
  • Major opportunities for new coagulation instruments and consumables. 
  • Profiles of  major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. 
  • Business opportunities and strategic recommendations for instrument and reagent suppliers.


    Worldwide Market and Technology Overview
    A. Major Routine and Special Coagulation Tests
    1. Introduction
    2. Activated Partial Thromboplastin Time (APTT)
    3. Alpha-2 Antiplasmin
    4. Antithrombin III
    5. Bleeding Time
    6. D-Dimer
    7. Ethanol Flocculation Test
    8. Euglobulin Lysis
    9. Factor Assays
    a. Introduction
    b. Factor II
    c. Factor V/Factor V Leiden
    d. Factor VII
    e. Factor VIII
    f. Factor IX
    g. Factor IXa
    h. Factor X (Stuart Factor)
    i. Factor Xa
    j. Factor XI
    k. Factor XII
    l. Factor XIII
    10. Fibrin Degradation Products
    11. Fibrinogen
    12. Heparin
    13. Hirudin
    14. Hypercoagulability and Thrombosis
    15. Lipoprotein a
    16. Plasmin
    17. Plasminogen
    18. Plasminogen Activator Inhibitor (PAI)
    19. Platelet Function Tests
    20. Platelet Aggregation

    21. Proteins C and S
    22. Prothrombin Fragment 1.2
    23. Prothrombin Time (PT)
    24. Reptilase Time
    25. Thrombin Time
    26. Tissue-Type Plasminogen Activator (t-PA)
    27. Von Willebrands Factor
    B. Instrumentation Review
    - Introduction
    - Benk Hemolab
    - Benk TRT Thrombotimer
    - Bio/Data MCA 310
    - Bio/Data MCA 210
    - Bio/Data PAP-4C D/4D/4C
    - Cardiovascular Diagnostics COAG
    - Diagnostica Stago STA Compact
    - Diagnostica Stago STA-R
    - Diagnostica Stago Star 4/8
    - Helena Laboratories Cascade 480
    - Helena Laboratories Cascade M
    - Helena Laboratories PACKS-4
    - Helena THOR
    - Instrumentation Laboratory ACL 100 and 1000 series
    - Instrumentation Laboratory ACL6000
    - Instrumentation Laboratory ACL7000
    - Instrumentation Laboratory ACL9000
    - Instrumentation Laboratory Electra 1000C
    - Instrumentation Laboratory Electra 1400C
    - Instrumentation Laboratory Electra 1600/C
    - Instrumentation Laboratory Electra 1800C
    - Instrumentation Laboratory Futura
    - ITC Hemochron 8000
    - Roche Diagnostics CoaguChek
    - Siemens BCS
    - Siemens BCT
    - Siemens BF II/Fibrintimer Series
    - Sysmex CA-50
    - Sysmex CA-500
    - Sysmex CA-1500

    - Sysmex CA-5000/CA-1000
    - Sysmex CA-6000
    - Sysmex CA-7000
    - Teco Coatron II/Jr./AccuStasis 5000
    - Trinity Biotech Amax CS190
    - Trinity Biotech Amax CS400
    - Trinity Biotech Coag-A-Mate Max
    - Trinity Biotech KC 40, 4A, 1A Series
    - Trinity Biotech MDA 180
    - Trinity Biotech Coag-A-Mate MTX
    - Trinity Biotech Coag-A-Mate RA4
    - Trinity Biotech Coag-A-Mate XC/Plus
    - Trinity Biotech Coag-A-Mate XM
    C. Major in Vitro Diagnostic Technologies and Their
    Potential Applications
    1. Chromogenic Substrates
    2. Monoclonal and Polyclonal Antibodies
    3. Immunoassays
    a. Applications
    b. Technological Principle
    c. Enzyme Immunoassays (EIA)
    - Overview
    - ELISA
    - EMIT
    - Dot Immunobinding Assays
    - Capillary Immunoassays
    - Enzyme Amplification
    - Electrochemical Immunoassay
    d. Fluorescent Immunoassays
    - Fluorescence Polarization
    - Time-Resolved Pulse Fluorescence
    - Fluorescence Lifetime
    e. Latex Agglutination
    f. Immunoprecipitation
    4. Microcomputers
    5. Automation
    6. Robotics
    7. DNA Probes
    a. Overview
    b. Amplification Methods


    - PCR
    - Ligase Chain Reaction
    - Branched DNA
    - Q-Beta Replicase
    - NASBA
    - SDA
    - 3 SR
    - HPA
    - Two-Tiered System
    - LAT
    8. Artificial Intelligence
    9. Dry Chemistry
    10. Biosensors

    USA
    A. Executive Summary
    B. Business Environment
    1. Health Care Expenditures
    2. Cost Consciousness
    3. Industry Consolidation
    4. Managed Care
    5. Hospitals
    6. Admissions
    7. Length of Stay
    8. Industry Diversification
    9. Physician Demographics
    10. Population Aging
    a. Chronic Illnesses
    b. Disease Incidence
    c. Susceptibility to Iatrogenesis
    d. Multiple Illness Cases
    11. Laboratory Regulations
    C. Market Structure
    1. Centralized Testing
    a. Hospitals
    b. Commercial laboratories
    2. Decentralized Testing
    a. Physician Offices/Group Practices
    b. Point-of-Care Testing
    c. Home/Self Testing
    d. Other Decentralized Testing Locations
    D. Market Size, Growth And Major Suppliers

    Major Product Development Opportunities
    Design Criteria For Decentralized Testing Products
    Alternative Market Penetration Strategies
    A. Internal Development
    B. Collaborative Arrangements
    C. University Contracts
    D. Distribution Strategies for Decentralized Testing Markets
    1. Marketing Approaches
    2. Product Complexity
    3. Customer Preference
    4. Established Suppliers
    5. Emerging Suppliers
    6. Major Types Of Distributors
    7. Market Segmentation
    Potential Market Entry Barriers And Risks
    A. Market Maturity
    B. Cost Containment
    C. Competition
    D. Technological Edge And Limitations
    E. Patent Protection
    F. Regulatory Constraints
    G. Decentralized Testing Market Challenges
    Competitive Assessments
    - Abbott
    - ADI/American Diagnostica
    - Alere/Biosite/Inverness
    - Axis-Shield
    - Beckman Coulter
    - Becton Dickinson
    - Bio/Data Corporation
    - Chrono-Log
    - Corgenix Medical
    - Diagnostica Stago
    - Grifols
    - Helena Laboratories
    - HYPEN BioMed

    - Instrumentation Laboratory
    - ITC
    - Roche
    - Siemens
    - Sienco
    - Sysmex
    - Thermo Fischer
    - Trinity Biotech
    - ZyCare/Alere

    List Of Tables


    Major Companies Developing or Marketing Activated Clotting Time Tests
    Major Companies Developing or Marketing APTT Tests
    Major Companies Developing or Marketing Alpha-2 Antiplasmin Tests
    Major Companies Developing or Marketing Antithrombin III Tests
    Major Companies Developing or Marketing Bleeding Time Tests
    Major Companies Developing or Marketing D-dimer Tests
    Major Companies Developing or Marketing Factor Assays
    Major Companies Developing or Marketing Fibrin Degradation
    Product Tests
    Major Companies Developing or Marketing Fibrinogen Tests
    Major Companies Developing or Marketing Heparin Tests
    Major Companies Developing or Marketing Plasmin Tests
    Major Companies Developing or Marketing Plasminogen Tests
    Major Companies Developing or Marketing Plasminogen Activator
    Inhibitor Tests
    Major Companies Developing or Marketing Platelet Aggregation Tests

    Major Companies Developing or Marketing Protein C Tests
    Major Companies Developing or Marketing Protein S Tests
    Major Companies Developing or Marketing PT Tests
    Major Companies Developing or Marketing Thrombin Time Tests
    Major Companies Developing or Marketing TPA Tests

    Major Companies Developing or Marketing Von Willebrands
    Factor Tests
    Executive Summary Table: U.S.A., Hospital Coagulation Diagnostics
    Market By Product Category
    U.S.A., Hospital Laboratories Performing Coagulation Tests
    By Bed Size
    U.S.A., Hospital Laboratories Average Daily Test Volume
    U.S.A., Hospital Laboratories Coagulation Test Volume by Assay
    U.S.A., Major Suppliers of Coagulation Reagents,
    Estimated Sales and Market Shares
    U.S.A., Major Suppliers of Coagulation Analyzers,
    Estimated Sales and Market Shares
    U.S.A., Coagulation Diagnostics Market By Product Category
    U.S.A., Major Suppliers of Coagulation Diagnostic Products,
    Estimated Sales and Market Shares

    Cyprus Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: Supplier Shares and Strategies, Volume and Sales Forecasts, Technology and Instrumentation Review

    This comprehensive report contains 350 pages, 22 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next five years.

    USD 2750 View Report

    Austria Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: Supplier Shares and Strategies, Volume and Sales Forecasts, Technology and Instrumentation Review

    This comprehensive report contains 350 pages, 22 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging business opportunities during the next five years.

    USD 2750 View Report

    US Hospital Clinical Chemistry and Immunodiagnostics Market for 100 Tests: Supplier Shares and Sales Forecasts, 2019-2023

    This new report contains 543 pages, 63 tables, and presents a comprehensive analysis of the US hospital clinical chemistry and immunodiagnostics market, including: Major issues pertaining to the US clinical chemistry

    USD 3500 View Report

    U.K. Hospital Hemostasis Testing Market: Forecasts for 40 Coagulation Assays, Supplier Shares, 2019-2023

    This new report contains 402 pages, 28 tables, and presents a comprehensive analysis of the UK hospital coagulation testing market, including: Major issues pertaining to the UK coagulation laboratory practice, as

    USD 3500 View Report

    Fill The Form For Sample Request

    Note : * Kindly provide us with your company id and get the sample reports at the earliest.

    There is no Reviews available